In contrast to neuroaxonal damage, glial activation (as indicated by GFAP and CHI3L1 [54,55,56]) apparently does not differ between MRZR+ and MRZR- PPMS patients. The gene discussed is GFAP; the disease is primary progressive multiple sclerosis.